Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions to Acquire GeneMachines for $8.3M

NEW YORK, March 3 - Genomic Solutions, a wholly owned subsidiary of Harvard Bioscience, said today that it plans to acquire genomic tool company GeneMachines for around $8.3 million in cash.


The acquisition is expected to close in mid March, subject to the approval of GeneMachines' shareholders. According to Harvard Bioscience, enough GeneMachines shareholders necessary to approve the transaction have already entered agreed to vote in favor of the acquisition.


GeneMachines develops and distributes high-throughput instrumentation for DNA and protein microarray production, nucleic acid sample preparation, and DNA synthesis.


Click here for further information.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.